Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.
Li LL, Qu LL, Fu HJ, Zheng XF, Tang CH, Li XY, Chen J, Wang WX, Yang SX, Wang L, Zhao GH, Lv PP, Zhang M, Lei YY, Qin HF, Wang H, Gao HJ, Liu XQ.
Li LL, et al. Among authors: qu ll.
Oncotarget. 2017 Jul 11;8(28):45399-45414. doi: 10.18632/oncotarget.17535.
Oncotarget. 2017.
PMID: 28514730
Free PMC article.